Gainers
- Nivalis Therapeutics Inc (NASDAQ: NVLS) rose 14.4 percent to $3.02 in pre-market trading after the company announced a merger deal with Alpine Immune Sciences.
April 19, 2017 at 06:00PM
from Lisa Levin
Featured Post
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment